TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...
Russia's announcement of a personalised mRNA cancer vaccine has generated excitement, but experts urge caution. While mRNA technology shows potential, the lack of clinical data and the gap between ...
Researchers developed a technique to gain a deeper understanding of ribosome function and their cooperative behaviors.
The ICMR has initiated the process of development of an ingenious human vaccine candidate against highly-pathogenic avian ...
News Medical on MSN1d
Disrupting the RBM42 protein could throw a wrench in the gears of cancer's growthFor decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many ...
For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many cancers manage to overcome this and continue growing. Now, scientists think they ...
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
UCSF scientists discover how cancer cells hijack the protein factory of the cell to churn out MYC protein, the driver of 70% ...
TriLink BioTechnologies, a Maravai LifeSciences (MRVI) company and global provider of life science reagents and services, has signed a ...
Mpox, Oncology Therapies and AI Integration Positions GeoVax for Strong Momentum ATLANTA, GA - February 5, 2025 (NEWMEDIAWIRE ...
Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a Memorandum of Understanding which ...
The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback